Category Archives: Specialty Drug

Xspray Pharma Partners with EVERSANA for Launch and Commercialization of Dasynoc (XS004)

Xspray Pharma signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc

Cigna Restricts Coverage for Amylyx Pharmaceutical’s ALS Drug Relyvrio

Cigna restricts coverage for Amylyx Pharmaceutical’s ALS drug Relyvrio due to the lack of clinical efficacy data and unclear clinical benefit

Oak Hill Capital Announced the Formation of Petauri Health

Oak Hill Capital partnered with Dan Renick to launch Petauri Health, a purpose-built pharmaceutical commercialization services platform

Independence Blue Cross Launches Gene Therapeutics Network

BlueCross Blue Shield Plans: Access Market Intelligence

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

Eisai Selects Soleo Health as Sole Specialty Pharmacy Provider for Leqembi

Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, was selected by Eisai as the sole specialty pharmacy distribution partner for Leqembi

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities

Arcutis Biotherapeutics’ Launches ZORYVE to Treat Plague Psoriasis

Arcutis recently announced that ZORYVE (roflumilast) cream 0.3% for topical use is now available in the United States for the treatment of plaque psoriasis in people aged 12 and older